ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 65 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $21,000 | +425.0% | 20,310 | +246.4% | 0.00% | – |
| Q4 2018 | $4,000 | -85.7% | 5,864 | -54.6% | 0.00% | – |
| Q3 2018 | $28,000 | -3.4% | 12,922 | +4.8% | 0.00% | – |
| Q2 2018 | $29,000 | +31.8% | 12,332 | +77.0% | 0.00% | – |
| Q1 2018 | $22,000 | -12.0% | 6,967 | +13.9% | 0.00% | – |
| Q4 2017 | $25,000 | -84.7% | 6,117 | -83.0% | 0.00% | – |
| Q3 2017 | $163,000 | +71.6% | 36,055 | +26.2% | 0.00% | – |
| Q2 2017 | $95,000 | -90.2% | 28,579 | -73.0% | 0.00% | – |
| Q1 2017 | $974,000 | -42.0% | 105,694 | -51.5% | 0.00% | – |
| Q4 2016 | $1,680,000 | +66.2% | 217,886 | +146.2% | 0.00% | – |
| Q3 2016 | $1,011,000 | +225.1% | 88,516 | +251.1% | 0.00% | – |
| Q2 2016 | $311,000 | +45.3% | 25,214 | +19.3% | 0.00% | – |
| Q1 2016 | $214,000 | -93.7% | 21,140 | -85.9% | 0.00% | -100.0% |
| Q4 2015 | $3,387,000 | +85.4% | 150,262 | +36.5% | 0.00% | 0.0% |
| Q3 2015 | $1,827,000 | -21.9% | 110,084 | +5.9% | 0.00% | 0.0% |
| Q2 2015 | $2,339,000 | -11.6% | 103,945 | +1.2% | 0.00% | 0.0% |
| Q1 2015 | $2,646,000 | +29.6% | 102,683 | +9.5% | 0.00% | 0.0% |
| Q4 2014 | $2,041,000 | +48.8% | 93,809 | +29.4% | 0.00% | 0.0% |
| Q3 2014 | $1,372,000 | +1082.8% | 72,475 | +1360.9% | 0.00% | – |
| Q2 2014 | $116,000 | -91.3% | 4,961 | -87.5% | 0.00% | -100.0% |
| Q1 2014 | $1,337,000 | +285.3% | 39,722 | +238.2% | 0.00% | – |
| Q4 2013 | $347,000 | +121.0% | 11,744 | +14.7% | 0.00% | – |
| Q3 2013 | $157,000 | – | 10,241 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|